Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B

Acute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old w...

Full description

Bibliographic Details
Main Authors: Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2018-12-01
Series:Clinical and Molecular Hepatology
Subjects:
Online Access:http://e-cmh.org/upload/pdf/cmh-2017-0016.pdf
_version_ 1811210537467379712
author Hyeji Kim
Jung Hyun Kwon
Yong Hee Kim
Soon Woo Nam
Jong Yul Lee
Jeong Won Jang
author_facet Hyeji Kim
Jung Hyun Kwon
Yong Hee Kim
Soon Woo Nam
Jong Yul Lee
Jeong Won Jang
author_sort Hyeji Kim
collection DOAJ
description Acute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old woman who experienced ACLF due to CHB exacerbation and was treated with a combination of corticosteroids and nucleot(s)ide analogue (NUC). The patient showed rapid decompensation due to CHB exacerbation. Three months of antiviral therapy produced no improvement in liver function. Combination therapy with corticosteroids and NUC was started, which did result in improvement of liver function. This case shows that the combined therapy of corticosteroids and NUC can be effective in treating ACLF due to CHB exacerbation.
first_indexed 2024-04-12T04:57:16Z
format Article
id doaj.art-d56cf86ce07e4595a6428c1c795e987b
institution Directory Open Access Journal
issn 2287-2728
2287-285X
language English
last_indexed 2024-04-12T04:57:16Z
publishDate 2018-12-01
publisher Korean Association for the Study of the Liver
record_format Article
series Clinical and Molecular Hepatology
spelling doaj.art-d56cf86ce07e4595a6428c1c795e987b2022-12-22T03:47:06ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2018-12-0124443043510.3350/cmh.2017.00161390Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis BHyeji Kim0Jung Hyun Kwon1Yong Hee Kim2Soon Woo Nam3Jong Yul Lee4Jeong Won Jang5 Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary’s Hospital, Incheon, Korea Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary’s Hospital, Incheon, Korea Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary’s Hospital, Incheon, Korea Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary’s Hospital, Incheon, Korea Department of Internal Medicine, The Catholic University of Korea Incheon St. Mary’s Hospital, Incheon, Korea Department of Internal Medicine, The Catholic University of Korea Seoul St. Mary’s Hospital, Seoul, KoreaAcute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old woman who experienced ACLF due to CHB exacerbation and was treated with a combination of corticosteroids and nucleot(s)ide analogue (NUC). The patient showed rapid decompensation due to CHB exacerbation. Three months of antiviral therapy produced no improvement in liver function. Combination therapy with corticosteroids and NUC was started, which did result in improvement of liver function. This case shows that the combined therapy of corticosteroids and NUC can be effective in treating ACLF due to CHB exacerbation.http://e-cmh.org/upload/pdf/cmh-2017-0016.pdfacute-on-chronic liver failurechronic hepatitis bcorticosteroidexacerbationreactivation
spellingShingle Hyeji Kim
Jung Hyun Kwon
Yong Hee Kim
Soon Woo Nam
Jong Yul Lee
Jeong Won Jang
Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
Clinical and Molecular Hepatology
acute-on-chronic liver failure
chronic hepatitis b
corticosteroid
exacerbation
reactivation
title Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
title_full Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
title_fullStr Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
title_full_unstemmed Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
title_short Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
title_sort favorable effect of corticosteroids in treating acute on chronic liver failure underlying chronic hepatitis b
topic acute-on-chronic liver failure
chronic hepatitis b
corticosteroid
exacerbation
reactivation
url http://e-cmh.org/upload/pdf/cmh-2017-0016.pdf
work_keys_str_mv AT hyejikim favorableeffectofcorticosteroidsintreatingacuteonchronicliverfailureunderlyingchronichepatitisb
AT junghyunkwon favorableeffectofcorticosteroidsintreatingacuteonchronicliverfailureunderlyingchronichepatitisb
AT yongheekim favorableeffectofcorticosteroidsintreatingacuteonchronicliverfailureunderlyingchronichepatitisb
AT soonwoonam favorableeffectofcorticosteroidsintreatingacuteonchronicliverfailureunderlyingchronichepatitisb
AT jongyullee favorableeffectofcorticosteroidsintreatingacuteonchronicliverfailureunderlyingchronichepatitisb
AT jeongwonjang favorableeffectofcorticosteroidsintreatingacuteonchronicliverfailureunderlyingchronichepatitisb